Ratings changes for Sangamo Therapeutics, bluebird bio, Verastem, Heron Therapeutics, Syros Pharmaceuticals, Cellectis, Vivid Seats and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
CEO Mark Zuckerberg sold 2,311 shares of the stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $600.21, for a total transaction of $1,387,085.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Ralph Lauren (NYSE:RL) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $250.00 price target on the stock. This represents a 6.9% upside from the current price of $233.97.
Yum! Brands (NYSE:YUM) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $155.00 price target on the stock. This represents a 15.3% upside from the current price of $134.40.
Canoo (NASDAQ:GOEV) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $0.50 price target on the stock, down previously from $4.50. This represents a 63.1% downside from the current price of $1.36.
Ducommun (NYSE:DCO) is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating and a $72.00 price target on the stock. This represents a 17.1% upside from the current price of $61.50.
RPT Realty (NYSE:RPT) is now covered by analysts at Janney Montgomery Scott. They set a “buy” rating and a $4.00 price target on the stock. This represents a 36.5% upside from the current price of $2.93.
Treace Medical Concepts (NASDAQ:TMCI) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $14.50 price target on the stock. This represents a 104.2% upside from the current price of $7.10.
Vertex (NASDAQ:VERX) is now covered by analysts at DA Davidson. They set a “buy” rating and a $62.00 price target on the stock. This represents a 16.3% upside from the current price of $53.29.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Co. (MSFT)
